BIOMAT Database Logo BIOMAT Database Logo

In vitro and in vivo activation of CD4+ lymphocytes by autologous tumor cells. 1990

C Gravekamp, and M Bontenbal, and C P Ronteltap, and D Van Duyvenbode, and R L Bolhuis
Department of Immunology, Dr Daniel den Hoed Cancer Center, Rotterdam, The Netherlands.

UI MeSH Term Description Entries
D007959 Lymphocyte Culture Test, Mixed Measure of histocompatibility at the HL-A locus. Peripheral blood lymphocytes from two individuals are mixed together in tissue culture for several days. Lymphocytes from incompatible individuals will stimulate each other to proliferate significantly (measured by tritiated thymidine uptake) whereas those from compatible individuals will not. In the one-way MLC test, the lymphocytes from one of the individuals are inactivated (usually by treatment with MITOMYCIN or radiation) thereby allowing only the untreated remaining population of cells to proliferate in response to foreign histocompatibility antigens. Leukocyte Culture Test, Mixed,Mixed Lymphocyte Culture Test,Mixed Lymphocyte Reaction,Mixed Leukocyte Culture Test,Mixed Leukocyte Reaction,Leukocyte Reaction, Mixed,Leukocyte Reactions, Mixed,Lymphocyte Reaction, Mixed,Lymphocyte Reactions, Mixed,Mixed Leukocyte Reactions,Mixed Lymphocyte Reactions
D008213 Lymphocyte Activation Morphologic alteration of small B LYMPHOCYTES or T LYMPHOCYTES in culture into large blast-like cells able to synthesize DNA and RNA and to divide mitotically. It is induced by INTERLEUKINS; MITOGENS such as PHYTOHEMAGGLUTININS, and by specific ANTIGENS. It may also occur in vivo as in GRAFT REJECTION. Blast Transformation,Blastogenesis,Lymphoblast Transformation,Lymphocyte Stimulation,Lymphocyte Transformation,Transformation, Blast,Transformation, Lymphoblast,Transformation, Lymphocyte,Activation, Lymphocyte,Stimulation, Lymphocyte
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D015496 CD4-Positive T-Lymphocytes A critical subpopulation of T-lymphocytes involved in the induction of most immunological functions. The HIV virus has selective tropism for the T4 cell which expresses the CD4 phenotypic marker, a receptor for HIV. In fact, the key element in the profound immunosuppression seen in HIV infection is the depletion of this subset of T-lymphocytes. T4 Cells,T4 Lymphocytes,CD4-Positive Lymphocytes,CD4 Positive T Lymphocytes,CD4-Positive Lymphocyte,CD4-Positive T-Lymphocyte,Lymphocyte, CD4-Positive,Lymphocytes, CD4-Positive,T-Lymphocyte, CD4-Positive,T-Lymphocytes, CD4-Positive,T4 Cell,T4 Lymphocyte
D050378 T-Lymphocytes, Regulatory CD4-positive T cells that inhibit immunopathology or autoimmune disease in vivo. They inhibit the immune response by influencing the activity of other cell types. Regulatory T-cells include naturally occurring CD4+CD25+ cells, IL-10 secreting Tr1 cells, and Th3 cells. Regulatory T Cell,Regulatory T-Cell,Regulatory T-Lymphocyte,Regulatory T-Lymphocytes,Suppressor T-Lymphocytes, Naturally-Occurring,T-Cells, Regulatory,Th3 Cells,Tr1 Cell,Treg Cell,Regulatory T-Cells,Suppressor T-Cells, Naturally-Occurring,Tr1 Cells,Treg Cells,Cell, Regulatory T,Cell, Th3,Cell, Tr1,Cell, Treg,Cells, Regulatory T,Cells, Th3,Cells, Tr1,Cells, Treg,Naturally-Occurring Suppressor T-Cell,Naturally-Occurring Suppressor T-Cells,Naturally-Occurring Suppressor T-Lymphocyte,Naturally-Occurring Suppressor T-Lymphocytes,Regulatory T Cells,Regulatory T Lymphocyte,Regulatory T Lymphocytes,Suppressor T Cells, Naturally Occurring,Suppressor T Lymphocytes, Naturally Occurring,Suppressor T-Cell, Naturally-Occurring,Suppressor T-Lymphocyte, Naturally-Occurring,T Cell, Regulatory,T Cells, Regulatory,T Lymphocytes, Regulatory,T-Cell, Naturally-Occurring Suppressor,T-Cells, Naturally-Occurring Suppressor,T-Lymphocyte, Regulatory,Th3 Cell

Related Publications

C Gravekamp, and M Bontenbal, and C P Ronteltap, and D Van Duyvenbode, and R L Bolhuis
In vivo distribution of cytotoxic lymphocytes specifically stimulated against autologous tumor cells in vitro.
August 1983, Nihon Gan Chiryo Gakkai shi,
C Gravekamp, and M Bontenbal, and C P Ronteltap, and D Van Duyvenbode, and R L Bolhuis
[Cytotoxicity of lymphocytes sensitized by autologous tumor cells in vitro, against autologous lung cancer cell lines].
April 1990, Nihon Geka Gakkai zasshi,
C Gravekamp, and M Bontenbal, and C P Ronteltap, and D Van Duyvenbode, and R L Bolhuis
Lysis of fresh human solid tumor cells by autologous lymphocytes activated in vitro by allosensitization.
January 1983, Cancer immunology, immunotherapy : CII,
C Gravekamp, and M Bontenbal, and C P Ronteltap, and D Van Duyvenbode, and R L Bolhuis
Human pancreatic cancer cells (MPanc-96) recognized by autologous tumor-infiltrating lymphocytes after in vitro as well as in vivo tumor expansion.
June 1997, International journal of cancer,
C Gravekamp, and M Bontenbal, and C P Ronteltap, and D Van Duyvenbode, and R L Bolhuis
In-vitro activation and reinfusion of autologous human lymphocytes.
November 1968, Lancet (London, England),
C Gravekamp, and M Bontenbal, and C P Ronteltap, and D Van Duyvenbode, and R L Bolhuis
In vitro complement activation by rabbit lymphocytes and thymocytes in autologous serum.
May 1979, Immunology,
C Gravekamp, and M Bontenbal, and C P Ronteltap, and D Van Duyvenbode, and R L Bolhuis
[In vitro immune response of patient lymphocytes to live autologous tumor cells].
January 1980, Voprosy onkologii,
C Gravekamp, and M Bontenbal, and C P Ronteltap, and D Van Duyvenbode, and R L Bolhuis
CD4+ blood lymphocytes are rapidly killed in vitro by contact with autologous human immunodeficiency virus-infected cells.
August 1995, Proceedings of the National Academy of Sciences of the United States of America,
C Gravekamp, and M Bontenbal, and C P Ronteltap, and D Van Duyvenbode, and R L Bolhuis
Defective lymphokine production by most CD8+ and CD4+ tumor-specific T cell clones derived from human melanoma-infiltrating lymphocytes in response to autologous tumor cells in vitro.
September 1994, European journal of immunology,
C Gravekamp, and M Bontenbal, and C P Ronteltap, and D Van Duyvenbode, and R L Bolhuis
Lesion-specific activation of cloned human tumor-infiltrating lymphocytes by autologous tumor cells: induction of proliferation and cytokine production.
July 1993, The Journal of investigative dermatology,
Copied contents to your clipboard!